Loading

International Journal of Plant Biology & Research

Screening of Phytochemicals and In silico Approach through Drug Design of Centella asiatica

Research Article | Open Access | Volume 7 | Issue 1

  • 1. Tectona Biotech Resource Centre, India
+ Show More - Show Less
Corresponding Authors
Soubhagyalaxmi Sahoo, Tectona Biotech Resource Centre (TBRC), Bhubaneswar, Odisha, India, Tel: 9337524676
Abstract

Centellaasiatica is a valuable medicinal herbaceous aromatic creeper which has been valued for centuries in ayurvedic medicine. Phytochemical analysis of Centellaasiatica plant extracts revealed the presence of various biochemical compounds such as alkaloids, flavonoids, glycosides, triterpenoids and saponins etc. Since triterpenoids and flavonoids have remarkable anti-inflammatory activity also Phyto compound possess a wide range of activities, which may help in protection against tuberculosis diseases. In this study, the molecular docking was applied to explore the binding mechanism and to correlate its docking score with the activity of plant derived compounds and also identified targets were validated through some other databases to select the better ones and design the drug. This study reveals that NOD2 is a better potential drug target for tuberculosis and Quercetin is the best ligand to inhibit NOD2 and might be prevent the disease Tuberculosis. Our result can be useful for the design and development of novel compounds having better inhibitory activity against several type of Tuberculosis. This potential agent will be a promising candidate can further be validated in research for its proper function. This work would help to design a potent lead molecule against any other disease.

Citation

Sahoo S, Raut SS, Das D (2019) Screening of Phytochemicals and In silico Approach through Drug Design of Centella asiatica. Int J Plant Biol Res 7(1): 1114.

Keywords

•    Tb
•    Blast
•    Kegg
•    String
•    Malacard
•    Mitarbase

INTRODUCTION

A Tuberculosis (TB) is an infectious disease, spreads through the air. Currently, one third of the world’s population is infected with tuberculosis and each year there are 2 - 3 million deaths worldwide caused by the disease [1]. TB is a leading cause of death among people with human immunodeficiency virus (HIV). Individuals infected with HIV are very susceptible to TB and often develop this disease before other manifestations of AIDS become apparent .It has been made to enrich the knowledge of antimycobacterial activity of Centella asiatica plant extract against Mycobacterium tuberculosis [2].The development of drug resistance in human pathogens against commonly used antibiotics has necessitated a search for new antimicrobial substances from other sources including plants [3]. Hence the sensitivity study of bacterial strains to the plant Centella asiatica was evaluated. Centella has been used as a wound-healing agent and a constituent of a brain tonic for the mentally challenged [4]. It has also been reported to be useful in the treatment of inflammations, diarrhea, asthma, tuberculosis and various skin lesions and ailments like leprosy, lupus, psoriasis and keloid [5]. In addition, numerous clinical reports verify the ulcer-preventive and antidepressive sedative effects of C. asiatica preparations, as well as their ability to improve venous insufficiency and microangiopathy [6]. Oil is known to be strong antimicrobial and antitumor agents [7]. The essential oil of Centella showed a broad spectrum of antibacterial activities against Gram-positive (Bacillus subtilis, Staphylococcus aureus) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Shigellasonnei) organisms. Activity against Gram-positive bacteria was greater than against Gram negatives. Germacrene compounds in the essential, an attempt has been made to enrich the knowledge of antimycobacterial activity of Centella asiatica plant extract against Mycobacterium tuberculosis [2].

In silico drug design can take part considerably in all stages of drug development from the preclinical discovery stage to late stage clinical development. Its exploitation in drug development helps in the selection of only a potent lead molecule and. In silico methods have been of great importance in target identification and in prediction of novel drugs. So through in silico approach we can design a new lead compound of Centella asiatica plant that can be helpful for human being as curing disease [8,9].

MATERIALS AND METHODS

Selection of target protein

To analyse the involvement of accrued target genes in unique metabolic pathways of Tuberculosis the pathway analysis was executed through KEGG (Kyoto Encyclopedia of Genes and Genomes) database (https://www.kegg.jp/), which is a resource for understanding high-level functions and utilities of the biological system and the pathway map represents the molecular interaction network diagram to explore the genomic relationship between the genes and the species. From this study 106 numbers of genes were selected for further studies.

Protein network enrichment

The Search Tool for the Retrieval of Interacting Genes (http:// string.embl.de/) database is an online tool designed to construct a PPI network and analyse the functional interactions between proteins. Thus here the use of STRING was justified with enrich the protein-protein network between the collected target genes.

Validation

MalaCards (http://www.malacards.org/#) is an integrated database of human maladies and their annotations, modelled on the architecture of human genes. The MalaCards disease database integrates both specialized and general disease lists, including rare diseases, genetic diseases, complex disorders and more. In this present study MalaCards was used to identify the targeted genes from the selected genes through KEGG and STRING database, which were highly involved in causing tuberculosis.

Protein preparation

The selected target genes of tuberculosis were analysed in UniProt (www.uniprot.org) database to know their sub cellular localization and retrieve the protein information of related genes. BLASTp used for protein database using protein query that was used to carry out the study by analysing the most similar structure with the target protein by sequence alignment process for further analysis.

Screening of target miRNAs

After the functional annotation this study came to investigate the associated target miRNAs from miRTarBase, which is the experimentally validated microRNA-target interactions database http://mirtarbase.mbc.nctu.edu.tw/php/index.php) and provides the most updated collection of more validated miRNA information in contrast to previously developed databases.

Selection of ligand

Pubchem (https://pubchem.ncbi.nlm.nih.gov/) is designed to provide information on biological activities of small molecules, generally those with molecular weight less than 500 Daltons. The plant C.asiatica has been used as brain tonic, and to treat chronic diseases and mental disorders. From brief literature survey, the Phytocompunds that is present in good quantity in the plant C.asiatica having selected for docking analysis.

Preparation of ligand

Open Babel is computer software, a chemical expert system mainly used to interconvert chemical file formats. The three dimensional structures of shortlisted 3 phytocompounds were downloaded from Pubchem in SDF format. The SDF files were then converted to PDB format using Open Babel converter and further used for molecular docking analysis.

Molecular docking

Computational docking can be used to predict bound conformations and free energies of binding for small molecule ligands to macromolecular targets. Docking analysis was done for the two target proteins with six different phyto compounds that are present in the plant P. amboinicus using Auto Dock tools. From this study an optimized conformation for both the protein and ligand and relative orientation between protein and ligand such that the free energy of the overall system was minimized. Data from the docking results of all docking processes were tabulated and best confirmations were selected. All the images were taken using PyMol (www.pymol.org ) software after in computational approaches.

Ligplot

LIGPLOT, are shown as dotted lines. Hydrophobic contacts are represented as spline curves that outline the hydrophobic parts of the ligand and are labelled by the contacting amino acid residues from the protein. Here, ligplot analysis was done to study the interaction between the proteins, ligand with different amino acid residues and also analysed the hydrogen bonds between the amino acids (Figure 1).

RESULT AND DISCUSSION

Retrieval of target genes

In total 106 number of target genes of tuberculosis were identified in KEGG pathway analysis, which were important genes involved in pathway to cause tuberculosis disease (Figure 2).

PPI Analysis

The Search Tool for the Retrieval of Interacting Genes (http://string.embl.de/) database is an online tool designed to construct a PPI network and analyze the functional interactions between proteins. Functional association, the 106 numbers of genes, which were retrieved from KEGG pathway database were subjected to STRING analysis to show the interaction rate between the targeted genes which was based on functions of respective proteins. There were total 62 numbers of genes were having interaction network out of 106 number of genes. The network was built based on the highest confidence score 0. 900. There were total 63 numbers of nodes, 143 numbers of edges, average node degree was 4.54, average local clustering co efficient was 0.436 and the PPI enrichment P value was < 1.0e-16 (Figure 3). This network might be provides the important drug targets for tuberculosis.

Validation

After the collection of target genes of tuberculosis, the validation was required to screen the good target for further analysis, so, for the validation all collected target genes, which were got from protein-protein interaction network through STRING analysis, were verified in MalaCards. As MalaCards is the human disease gene database, all the 62 genes of STRING result were searched in MalaCards database one by one to check the involvement of these genes in tuberculosis, as the reports present in MalaCards database are literature supported data sets, so the analysis through MalaCards is important. Thus, there were total 17 numbers of genes were identified through MalaCards search as those were involve in tuberculosis and also the MalaCard IDs were collected for all 17 number of selected genes for future analysis and review (Table 1).

The resulted 17 genes through MalaCards validation process were analysed or more validated through UniProt database, as it was mentioned above that UniProt is the collection of protein information database. So, The 6 numbers of genes were discarded because those genes were found as antigens and receptors and there were total 11 numbers of genes were considered as potential drug targets for tuberculosis out of 17 genes after UniProt database validation. Also the protein information like protein product names, amino acid length, UniProt IDs etc. of all the respective target genes were collected from UniProt for future prospectus (Table 2).

Further, binding affinity was explored using miRTarbase web server. So, in this present study the 11 selected putative drug targets for tuberculosis were searched in miRTarBase to collect their respective miRNAs. There were total 7 numbers of miRNAs were considered for 7 selected numbers of targeted genes which were collected based on the highest MFE score and its involvement in respective tuberculosis disease and also the strong evidence (Table 3).These miRNAs might be responsible to play an important role to cause disease, so the target miRNAs of target genes were also necessary to be inhibited by the putative drugs and subjected to further study.

Selection of natural compounds

As per literature survey, that are present in the plant C.asiaticathat have great inhibitory effects against diabetes. The resultant phytochemicals i.e. kaempferol, Myricetin, Querecetin were analyzed and prepared through computational approach and hence downloaded from PubChem database of NCBI web server (Table 4). Then for docking analysis the collected three dimensional structures of ligands in SDF format were converted in to PDB format with the help of Open Babel (Figure 4) and then used in docking analysis.

Molecular docking analysis

The results of molecular docking were intended for energetically favorable binding poses for each three natural compounds proposed drug target of C.asiatic. Many studies have reported the association between NOD2 polymorphisms and TB. The association between NOD2 and tuberculosis (TB) risk has been reported widely, but the results of previous studies remained controversial and ambiguous. To assess the association between NOD2 polymorphisms and TB risk, a meta-analysis was performed [10].The best binding interaction was seen by NOD2 protein with compound Kaempferol, Myricitin and Quercetin (Figure 5).

The binding energy of this docking result -7.45, -12.7, and -12.7 respectively, which was the best binding energy based on docking algorithms, resulted from all of the docking processes (Table 5). So this compound Quercetin could be used as an inhibitor to mutate and NOD2 gene as it has good binding affinity towards this gene. In docking results , amino acids residue of target NOD2 which undergo interaction with ligand Kaempferol , Myricetin and Quercetin were (arg159, Gla778, Trp741, His669, Glu158, Ser773, Trp157, Cys772, Ile673),(gly775, val774, ser773, glu778, ser801, phe408, leu411, leu410, asn409, gln450, pro776, phe447, gly446, thr777,glu449, glu158) and (glu158 ,trp741, glu773, ser773, Ile740, cys772, val774, trp157, asp379, his669, arg159) etc and the hydrogen bond was built between ligand with (Glu158 and Arg159) , (glu158, thr777, gly446, phe447, phe408, ser801, ser773) and (glu158, arg159, his669, trp157, glu778) respectively analysed through ligplot analysis as shown in Figure 6 (a,b,c).

In this study, C. asiatica is one of the important medicinal plants that have been used all over the world as unique sources of medicines and may constitute the most common human use of biodiversity. They are the richest bio-resource of traditional systems of medicine, modern medicines, food supplements, folk medicines, pharmaceutical intermediates and chemical entities for synthetic drugs. Tuberculosis (TB) is a contagious disease. Like the common cold, it spreads through the air. Only people who are sick with TB in their lungs are infectious. It has been made to enhance the knowledge of antimycobacterial activity of Centellaasiatica plant extract against Mycobacterium tuberculosis. The association between NOD2 and tuberculosis (TB) risk has been reported extensively, but the results of previous studies remained controversial and uncertain [10]. Despite the widespread use of an attenuated live vaccine and several antibiotics, there is more TB than ever before, requiring new vaccines and drugs and more specific and rapid diagnostics so the novel drug design should be needed for the better cure of the future disease management, but to design the new drug novel effective and validated drug targets also required. In sillico approach or computational methods to select targets, ligands in tuberculosis database and their refinement. This study reveals that NOD2 is a better potential drug target for tuberculosis and Quercetin is the best ligand to inhibit NOD2 and might be prevent the disease Tuberculosis.

CONCLUSION

In silico analysis provides the docking result, from which it was analysed that the compounds Kaempferol, Myricetin and quercetin were showed the 3 binding affinity i.e, -7.45, -12.61, ,-12.75 with the target protein NOD2 respectively, but out of these three only Quercetin showed the best binding affinity with target protein NOD2 i.e. -12.75 and bind with the protein perfectly. Also it had good active hydrogen bond interaction as compared to another compound. So it was concluded that Quercetin might be a good inhibitor against the target protein NOD2 to cure tuberculosis disease.

ACKNOWLEDGEMENT

We really thanks to Tectona Biotech Resource Centre (TBRC), Odisha, for providing necessary facilities, as well as we present our heartily gratitude to Dr.Shovan Kumar Mishra, Director of TBRC, for his endless support throughout this work.

REFERENCES

1. Chippada SC, Volluri SS, Srinivasa Rao B, Meena V. In vitro anti-inflammatory activity of methanolic extract of Centellaasiatica by HRBC membrane stabilisation. RASAYAN J Chem. 2011; 4: 457-460.

2. M. Suresh, Pradipta K Rath, A Panneerselvam, D Dhanasekaran, Nooruddin T. Anti-Mycobacterial Effect of Leaf Extract of Centellaasiatica (Mackinlayaceae). Res J. 2010; 872-876.

3. Dash BK, Faruquee HM, Sudhangshu KB, Md Khasrul A. “Antibacterial and Antifungal Activities of Several Extracts of Centellaasiatica L. against Some Human Pathogenic Microbes.” Res J. 2011.

4. Zainol MK, Azizah Abdul Hamid, S. Yusof, Shukri Muse. “Antioxidative activity and total phenolic compounds of leaf, root and petiole of four accessions of Centellaasiatica (L.) Urban.” Food Chem. 2003; 81: 575- 581.

5. Ullah MO, Sultana S, Haque A. Antimicrobial, cytotoxic and antioxidant activity of Centellaasiatica. Eur J Sci Res. 2009; 260-264.

6. Zheng CJ, Qin LP. Chemical components of Centellaasiatica and their bioactivities. Chinese J Integrat Med. 2007; 348-351.

7. Cheng CL, Koo MW. Effects of Centellaasiatica on ethanol induced gastric mucosal lesions in rats. Life Sci. 2000; 67: 2647-2653.

8. Laskowski RA, Swindells MB. “LigPlot+: multiple ligand–protein interaction diagrams for drug discovery.” J Chem Inf Model. 2011; 51: 2778-2786.

9. Šali Andrej, Tom L Blundell. “Comparative protein modelling by satisfaction of spatial restraints.” J Mol Biol. 1993; 234: 779-815.

10. Wang C, Chen ZL, Pan ZF, Wei LL, Xu DD, Jiang TT. NOD2 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis. Int J Biol Sci. 2013; 10: 103-108.

Sahoo S, Raut SS, Das D (2019) Screening of Phytochemicals and In silico Approach through Drug Design of Centella asiatica. Int J Plant Biol Res 7(1): 1114.

Received : 05 Oct 2019
Accepted : 11 Dec 2019
Published : 11 Dec 2019
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X